On this page of StockholderLetter.com we present the latest annual shareholder letter from Avalo Therapeutics, Inc. — ticker symbol AVTX. Reading current and past AVTX letters to shareholders can bring important insights into the investment thesis.
2024 ANNUAL REPORT Included in the 2024 Annual Report: Form 10-K (without exhibits) filed with the U.S. Securities and Exchange Commission on March 20, 2025
 • shareholder letter icon 5/1/2025 Letter Continued (Full PDF)
 • stockholder letter icon 10/19/2023 AVTX Stockholder Letter
 • stockholder letter icon 6/27/2024 AVTX Stockholder Letter
 • Benford's Law Stocks icon AVTX Benford's Law Stock Score = 79


AVTX Shareholder/Stockholder Letter Transcript:

2024 ANNUAL REPORT
Included in the 2024 Annual Report:
Form 10-K (without exhibits) filed with the U.S. Securities and Exchange Commission on
March 20, 2025



shareholder letter icon 5/1/2025 Letter Continued (Full PDF)
 

AVTX Stockholder/Shareholder Letter (Avalo Therapeutics, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2025, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.